- Filed
- Apr 29, 2026 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2026 · Apr 23, 2026 | 44.18M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2026 | 44.7M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2025 | 46.3M sh |
| Stock Repurchased | Q1 2026 · Mar 31, 2026 | $13.19M |
| Stock Repurchased | Q1 2026 · Mar 31, 2025 | $6.9M |
| Capex | Q1 2026 · Mar 31, 2026 | $9.48M |
| Capex | Q1 2026 · Mar 31, 2025 | $6.84M |
| Operating Cash Flow | Q1 2026 · Mar 31, 2026 | −$40.88M |
| Operating Cash Flow | Q1 2026 · Mar 31, 2025 | −$19.47M |
| Short Term Debt | Q1 2026 · Mar 31, 2026 | $89.78M |
| Short Term Debt | Q1 2026 · Dec 31, 2025 | $31.83M |
| Cash And Equivalents | Q1 2026 · Mar 31, 2026 | $80.4M |
| Cash And Equivalents | Q1 2026 · Dec 31, 2025 | $99.66M |
| Stockholders Equity | Q1 2026 · Mar 31, 2026 | $1.34B |
| Stockholders Equity | Q1 2026 · Dec 31, 2025 | $1.32B |
| Current Liabilities | Q1 2026 · Mar 31, 2026 | $379.75M |
| Current Liabilities | Q1 2026 · Dec 31, 2025 | $344.05M |
| Current Assets | Q1 2026 · Mar 31, 2026 | $1.02B |
| Current Assets | Q1 2026 · Dec 31, 2025 | $958.63M |
| Total Assets | Q1 2026 · Mar 31, 2026 | $2B |
| Total Assets | Q1 2026 · Dec 31, 2025 | $1.94B |
| Total Assets restated | Q1 2026 · Mar 31, 2025 | $1.93B |
| Eps Diluted | Q1 2026 · Mar 31, 2026 | $0.77 |
| Eps Diluted | Q1 2026 · Mar 31, 2025 | $0.67 |
| Eps Basic | Q1 2026 · Mar 31, 2026 | $0.77 |
| Eps Basic | Q1 2026 · Mar 31, 2025 | $0.67 |
| Sga Expense | Q1 2026 · Mar 31, 2026 | $123.01M |
| Sga Expense | Q1 2026 · Mar 31, 2025 | $119.64M |
| Net Income | Q1 2026 · Mar 31, 2026 | $34.33M |
| Net Income | Q1 2026 · Mar 31, 2025 | $30.96M |
| Operating Income | Q1 2026 · Mar 31, 2026 | $48.09M |
| Operating Income | Q1 2026 · Mar 31, 2025 | $44.1M |
| Gross Profit | Q1 2026 · Mar 31, 2026 | $174.97M |
| Gross Profit | Q1 2026 · Mar 31, 2025 | $163.9M |
| Cost Of Revenue | Q1 2026 · Mar 31, 2026 | $325.47M |
| Cost Of Revenue | Q1 2026 · Mar 31, 2025 | $291.34M |
| Revenue | Q1 2026 · Mar 31, 2026 | $500.44M |
| Revenue | Q1 2026 · Mar 31, 2025 | $455.25M |